EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSUMAG00000022988
Gene Symbol: MTOR
4 Cross references
214 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSUMAG00000002734
Gene Symbol: MC3R
4 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSUMAG00000004907
Gene Symbol: MC4R
4 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSUMAG00000012272
Gene Symbol: MTNR1A
4 Cross references
205 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSUMAG00000011878
Gene Symbol: MME
3 Cross references
228 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSUMAG00000025065
Gene Symbol: LOC103672632
3 Cross references
318 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSUMAG00000003511
Gene Symbol: METAP2
4 Cross references
214 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSUMAG00000015697
Gene Symbol: MAPT
2 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSUMAG00000003420
Gene Symbol: MAPK1
4 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSUMAG00000024932
Gene Symbol: MAPK10
4 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSUMAG00000010189
Gene Symbol: MAPK14
4 Cross references
280 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSUMAG00000011005
Gene Symbol: MAPK3
4 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).